A41Evaluation of safety and activity of everolimus plus exemestane in metastatic breast cancer: a single institution experience
Ferrarini, I., Bertolini, I., Fancelli, S., De Angelis, C., Fontana, A., Salvadori, B., Landucci, E., Michelotti, A., Falcone, A.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv336.41
Date:
October, 2015
File:
PDF, 30 KB
english, 2015